# A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral Drugs

> **NCT03537404** · PHASE1 · COMPLETED · sponsor: **R-Pharm** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Narlaprevir
- **DRUG:** Ritonavir
- **DRUG:** Tenofovir Disoproxil Fumarate
- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT03537404
- **Lead sponsor:** R-Pharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-24
- **Primary completion:** 2017-06-24
- **Final completion:** 2017-06-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03537404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03537404, "A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral Drugs". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03537404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*